PortfoliosLab logoPortfoliosLab logo
CIB0.DE vs. WELG.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

CIB0.DE vs. WELG.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CIB0.DE vs. WELG.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
-9.78%-10.00%5.16%2.09%-1.65%
WELG.DE
Amundi S&P Global Health Care ESG UCITS ETF EUR Dist
-4.84%1.26%7.51%1.94%-2.72%

Returns By Period

In the year-to-date period, CIB0.DE achieves a -9.78% return, which is significantly lower than WELG.DE's -4.84% return.


CIB0.DE

1D
1.37%
1M
-8.85%
YTD
-9.78%
6M
-3.29%
1Y
-11.01%
3Y*
-6.52%
5Y*
10Y*

WELG.DE

1D
1.38%
1M
-5.49%
YTD
-4.84%
6M
2.63%
1Y
-6.18%
3Y*
2.96%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CIB0.DE vs. WELG.DE - Expense Ratio Comparison

CIB0.DE has a 0.55% expense ratio, which is higher than WELG.DE's 0.18% expense ratio.


Return for Risk

CIB0.DE vs. WELG.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CIB0.DE
CIB0.DE Risk / Return Rank: 22
Overall Rank
CIB0.DE Sharpe Ratio Rank: 33
Sharpe Ratio Rank
CIB0.DE Sortino Ratio Rank: 33
Sortino Ratio Rank
CIB0.DE Omega Ratio Rank: 33
Omega Ratio Rank
CIB0.DE Calmar Ratio Rank: 22
Calmar Ratio Rank
CIB0.DE Martin Ratio Rank: 00
Martin Ratio Rank

WELG.DE
WELG.DE Risk / Return Rank: 66
Overall Rank
WELG.DE Sharpe Ratio Rank: 66
Sharpe Ratio Rank
WELG.DE Sortino Ratio Rank: 55
Sortino Ratio Rank
WELG.DE Omega Ratio Rank: 55
Omega Ratio Rank
WELG.DE Calmar Ratio Rank: 77
Calmar Ratio Rank
WELG.DE Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CIB0.DE vs. WELG.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CIB0.DEWELG.DEDifference

Sharpe ratio

Return per unit of total volatility

-0.56

-0.36

-0.20

Sortino ratio

Return per unit of downside risk

-0.68

-0.38

-0.29

Omega ratio

Gain probability vs. loss probability

0.92

0.95

-0.03

Calmar ratio

Return relative to maximum drawdown

-0.70

-0.33

-0.37

Martin ratio

Return relative to average drawdown

-1.80

-0.64

-1.15

CIB0.DE vs. WELG.DE - Sharpe Ratio Comparison

The current CIB0.DE Sharpe Ratio is -0.56, which is lower than the WELG.DE Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of CIB0.DE and WELG.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CIB0.DEWELG.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.56

-0.36

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.25

0.21

-0.46

Correlation

The correlation between CIB0.DE and WELG.DE is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

CIB0.DE vs. WELG.DE - Dividend Comparison

CIB0.DE has not paid dividends to shareholders, while WELG.DE's dividend yield for the trailing twelve months is around 1.57%.


TTM202520242023
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
0.00%0.00%0.00%0.00%
WELG.DE
Amundi S&P Global Health Care ESG UCITS ETF EUR Dist
1.57%1.36%0.92%0.17%

Drawdowns

CIB0.DE vs. WELG.DE - Drawdown Comparison

The maximum CIB0.DE drawdown since its inception was -26.12%, which is greater than WELG.DE's maximum drawdown of -23.11%. Use the drawdown chart below to compare losses from any high point for CIB0.DE and WELG.DE.


Loading graphics...

Drawdown Indicators


CIB0.DEWELG.DEDifference

Max Drawdown

Largest peak-to-trough decline

-26.12%

-23.11%

-3.01%

Max Drawdown (1Y)

Largest decline over 1 year

-15.52%

-15.57%

+0.05%

Current Drawdown

Current decline from peak

-24.58%

-13.23%

-11.35%

Average Drawdown

Average peak-to-trough decline

-9.86%

-6.89%

-2.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.06%

7.34%

-1.28%

Volatility

CIB0.DE vs. WELG.DE - Volatility Comparison

VanEck Bionic Engineering UCITS ETF A (CIB0.DE) has a higher volatility of 5.01% compared to Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE) at 4.16%. This indicates that CIB0.DE's price experiences larger fluctuations and is considered to be riskier than WELG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CIB0.DEWELG.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.01%

4.16%

+0.85%

Volatility (6M)

Calculated over the trailing 6-month period

12.42%

9.84%

+2.58%

Volatility (1Y)

Calculated over the trailing 1-year period

19.46%

17.12%

+2.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.80%

13.29%

+4.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.80%

13.29%

+4.51%